Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Pain Research"
DOI: 10.2147/jpr.s132595
Abstract: Background The buprenorphine transdermal system (BTDS) is approved in the US for the management of chronic pain. Due to its high affinity for μ-opioid receptors with a slow dissociation profile, buprenorphine may potentially displace or… read more here.
Keywords: use; supplemental analgesia; management; opioids supplemental ... See more keywords